Immuneering
(NASDAQ) IMRX
Immuneering Financials at a Glance
Market Cap
$352.36M
Revenue (TTM)
$0.00
Net Income (TTM)
$56.02M
EPS (TTM)
$-1.38
P/E Ratio
-3.95
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.47
Volume
17,169
Open
$5.24
Price
$5.47
Volume
17,169
Open
$5.24
Previous Close
$5.47
Daily Range
$5.24 - $5.54
52-Week Range
$1.10 - $10.08
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.47
Volume
17,169
Open
$5.24
Previous Close
$5.47
Daily Range
$5.24 - $5.54
52-Week Range
$1.10 - $10.08
IMRX News
IMRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Immuneering
Industry
Biotechnology
Sector
Health CareEmployees
37
CEO
Benjamin J. Zeskind, PhD, MBA
Website
www.immuneering.comHeadquarters
Cambridge, MA 02142, US
IMRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-43%
Return on Capital
-27%
Return on Assets
-24%
Earnings Yield
-25.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$352.36M
Shares Outstanding
64.65M
Volume
17.17K
Short Interest
0.00%
Avg. Volume
1.62M
Financials (TTM)
Gross Profit
$698.89K
Operating Income
$59.38M
EBITDA
$58.68M
Operating Cash Flow
$45.34M
Capital Expenditure
$142.22K
Free Cash Flow
$45.49M
Cash & ST Invst.
$172.83M
Total Debt
$3.82M
Immuneering Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$612.73K
-250.8%
Gross Margin
0.00%
N/A
Market Cap
$352.36M
N/A
Market Cap/Employee
$6.53M
N/A
Employees
54
N/A
Net Income
$11.58M
+35.9%
EBITDA
$13.74M
+23.1%
Quarterly Fundamentals
Net Cash
$169.01M
+428.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.43M
-10.4%
Short Term Debt
$397.10K
+17.3%
Return on Assets
-24.15%
N/A
Return on Invested Capital
-26.76%
N/A
Free Cash Flow
$9.96M
+31.4%
Operating Cash Flow
$9.84M
+32.2%